Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

China flag China · Delayed Price · Currency is CNY
19.50
+0.84 (4.50%)
Mar 10, 2026, 2:05 PM CST
241.51%
Market Cap 11.41B
Revenue (ttm) 1.14B
Net Income (ttm) -198.78M
Shares Out 611.69M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 22,122,112
Average Volume 13,062,631
Open 16.66
Previous Close 18.66
Day's Range 16.66 - 19.60
52-Week Range 4.82 - 19.60
Beta 1.07
RSI 65.01
Earnings Date Apr 25, 2026

About SHE:002082

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells orthopedic implant devices, including... [Read more]

Sector Healthcare
Founded 1985
Employees 1,499
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002082
Full Company Profile

Financial Performance

In 2024, SHE:002082's revenue was 1.44 billion, a decrease of -6.39% compared to the previous year's 1.54 billion. Earnings were 55.44 million, an increase of 12.66%.

Financial Statements

News

There is no news available yet.